Advanced Search

 

Study ID Status Title Patient Level Data
204853 Completed A Microdose Study to Describe the Intravenous Pharmacokinetics of GSK3191607 in Healthy Male Subjects Following Administration of [14C]-GSK3191607
204856 Completed A Phase I, Randomized, Placebo-Controlled, Double-Blind (sponsor unblind), Three Part Study to Evaluate the Safety, Tolerability, Preliminary PK and PD of Single and Repeat Oral Doses of GSK3008356 in Healthy Subjects and Obese Subjects
204857 Completed An Open-label Single-Center, 4-Period William’s Cross-Over Design Drug Interaction Trial to Determine the Effects of Sorbitol-Containing Solutions on Lamivudine Exposure Following Administration of Lamivudine Oral Solution in Healthy Adult Subjects
204860 Recruiting A double-blind (sponsor unblinded) study to investigate safety, tolerability, pharmacokinetics, pharmacodynamics and clinical effect of repeat dosing of GSK2646264 in cutaneous lupus erythematosus patients
204870 Completed A Clinical Study to Evaluate the Efficacy of an Experimental Mouthwash Formulation
204879 Terminated A Randomized, Open-label, Active-Controlled, Parallel-Group, Exploratory Study on the Effects of Repeated Doses of Albiglutide compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Subjects with Type 2 Diabetes Mellitus
204885 Withdrawn Skin Acceptability Assessment of the cosmetic product SM Peach Beige, in subjects with all Skin Types Under Normal Usage Conditions
204888 Not yet recruiting HO-15-15503 - Qualitative Interviews and Survey: Understanding how the attributes of Relvar/Breo convey patient benefits – Asthma and COPD
204889 Not yet recruiting Efficacy, safety and immunogenicity study of GSK Biologicals’ candi-date malaria vaccine (SB257049) evaluating schedules with or with-out fractional doses, early Dose 4 and yearly doses, in children 5-17 months of age
204890 Withdrawn Skin Acceptability Assessment of the cosmetic product SM Translucent, in subjects with all Skin Types Under Normal Usage Conditions.
204891 Withdrawn Skin Acceptability Assessment of the cosmetic product SM Light Beige, in subjects with all Skin Types Under Normal Usage Conditions.
204892 Withdrawn Skin Acceptability Assessment of the cosmetic product SB Translucent, in subjects with all Skin Types Under Normal Usage Conditions.
204896 Withdrawn Skin Acceptability Assessment of the cosmetic product SM Medium Beige, in subjects with all Skin Types Under Normal Usage Conditions.
204897 Withdrawn Skin Acceptability Assessment of the cosmetic product SB Peach Beige, in subjects with all Skin Types Under Normal Usage Conditions.
204898 Withdrawn Skin Acceptability Assessment of the cosmetic product SB Light Beige, in subjects with all Skin Types Under Normal Usage Conditions
204899 Withdrawn Skin Acceptability Assessment of the cosmetic product SB-Medium Beige, in subjects with all Skin Types Under Normal Usage Conditions.
204900 Completed PGx7642: Meta-analysis of data from FCGR PGx evaluations of ofatumumab CLL studies OMB110911, OMB114242, OMB115991 and OMB110913
204901 Completed PGx7644: Meta-analysis of data from SLE patients treated with Benlysta in studies BEL112341, BEL110752/BLISS-52/C1056, and BEL110751/BLISS-76/C1057
204905 Withdrawn Skin Acceptability Assessment of the cosmetic product SM Light Beige, in subjects with sensitive skin Under Normal Usage Conditions.
204906 Not yet recruiting Skin Acceptability Assessment of the cosmetic product SM Medium Beige, in subjects with sensitive skin Under Normal Usage Conditions
204907 Withdrawn Skin Acceptability Assessment of the cosmetic product SM Translucent, in subjects with sensitive skin Under Normal Usage Conditions
204908 Withdrawn Skin Acceptability Assessment of the cosmetic product SM Peach Beige, in subjects with sensitive skin Under Normal Usage conditions
204913 Recruiting A long-term follow-up study of the investigational GSK Biologicals’ GSK3277511A vaccine in adults
204917 Withdrawn Comedogenic and acnegenic potential evaluation with ophthalmologic evaluation of the cosmetic product SB Translucent - in-use study.
204918 Withdrawn Comedogenic and acnegenic potential evaluation with ophthalmologic evaluation of the cosmetic product SB Light Beige - in-use study.

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.